Showing results (201-210 of 210) with videos related to

Sort By:
Pageof 21
You have reached the last page of results.This site can display upto 210 results.
Der Chirurg; Zeitschrift Fur Alle Gebiete Der Operativen Medizen|February 25, 2003
[Prognostic relevance of biological and molecular markers in oncology. Criteria for planning and interpreting studies]E Bollschweiler, P M Schneider, S P Mönig, et al.
Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [Et Al.]|April 11, 2012
Losses at chromosome 4q are associated with poor survival in operable ductal pancreatic adenocarcinomaA M Luebke, M Baudis, H Matthaei, et al.
Annals of Surgery|December 1, 2001
Is there still a need for living-related liver transplantation in children?D C Broering, L Mueller, R Ganschow, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 8, 2013
VEGFR-2, CXCR-2 and PAR-1 germline polymorphisms as predictors of survival in pancreatic carcinomaF G Uzunoglu, J Kolbe, H Wikman, et al.
Critical Care Medicine|July 11, 2001
Attenuation of sepsis-related immunoparalysis by continuous veno-venous hemofiltration in experimental porcine pancreatitisE F Yekebas, C F Eisenberger, H Ohnesorge, et al.
Journal of Mass Spectrometry : JMS|January 25, 2017
MALDI imaging mass spectrometry reveals multiple clinically relevant masses in colorectal cancer using large-scale tissue microarraysA Hinsch, M Buchholz, S Odinga, et al.
Zentralblatt Fur Chirurgie|October 9, 2012
[Neuroendocrine tumours of the GI tract--data from the German NET Registry]N Begum, S Maasberg, U Plöckinger, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|December 27, 2018
Evaluation of the MDACC clinical classification system for pancreatic cancer patients in an European multicenter cohortF G Uzunoglu, M-N Welte, F Gavazzi, et al.
International Journal of Cancer|January 24, 2019
Germline BRCA2 K3326X and CHEK2 I157T mutations increase risk for sporadic pancreatic ductal adenocarcinomaO Obazee, L Archibugi, A Andriulli, et al.
Pageof 21